<?xml version="1.0" encoding="UTF-8"?>
<TEI xmlns="http://www.tei-c.org/ns/1.0" xml:lang="en">
  <teiHeader>
    <fileDesc>
      <titleStmt>
        <title>Parvalbumin-positive interneurons of the prefrontal cortex support working memory and cognitive flexibility</title>
        <author>Murray</author>
        <author>Woloszynowska-Fraser</author>
        <author>Ansel-Bollepalli</author>
        <author>Cole</author>
        <author>Foggetti</author>
        <author>Crouch</author>
        <author>Riedel</author>
        <author>Wulff</author>
      </titleStmt>
      <publicationStmt>
        <p>Tag layer of the DHSS Meta-Tagging Project. The article text is reproduced from the
           staged copy named in sourceDesc and is not altered; the tags are held separately in
           standOff so that overlapping and nested spans are preserved.</p>
      </publicationStmt>
      <sourceDesc>
        <bibl>
          <title>Parvalbumin-positive interneurons of the prefrontal cortex support working memory and cognitive flexibility</title>
          <date>2015</date>
          <publisher>Scientific Reports</publisher>
          <idno type="DOI">10.1038/srep16778</idno>
          
          <idno type="record">Murray2015-parvalbumin-positive-interneurons-of-the-pre</idno>
          <note type="staged-file">Murray2015-parvalbumin-positive-interneurons-of-the-pre.txt, the project's staged copy</note>
          <note type="text-sha1">eaa435b3c6b32cf4b8c62b21ad46f8ee42a5b9fd</note>
          <note type="rights">not-redistributable</note>
        </bibl>
      </sourceDesc>
    </fileDesc>
    <profileDesc>
      <textClass><keywords><term>neuroscience</term></keywords></textClass>
      <particDesc>
        <person xml:id="paper"><p>the paper's own words</p></person>
        <person xml:id="tagger"><p>the tag layer; a sentence written by the tagger about the
          paper, always anchored to a quotation but not itself a quotation</p></person>
      </particDesc>
    </profileDesc>
    <revisionDesc>
      <change when="2026-10-06"
              who="build_paper_edition.py">113 spans located by searching the stored text for the quote's exact words, allowing any whitespace between them</change>
    </revisionDesc>
  </teiHeader>
  <standOff>
    <spanGrp type="tags">
      <span xml:id="t0" from="#a5" to="#a6" type="object_of_study" ana="#object_of_study" resp="#paper">whether one class of prefrontal interneuron accounts for all of the behavioural consequences of prefrontal dysfunction, or only some</span>
      <span xml:id="t1" from="#a15" to="#a16" type="research_question" ana="#research_question" resp="#paper">which PFC-dependent behaviours require intact parvalbumin interneuron output, and which survive its loss</span>
      <span xml:id="t2" from="#a1" to="#a2" type="contribution" ana="#contribution" resp="#paper">shows that silencing PV interneurons reproduces the cognitive deficits of a whole-region lesion but none of the social or psychostimulant ones, so a composite syndrome maps onto separable circuit elements</span>
      <span xml:id="t3" from="#a1" to="#a2" type="claim_type" ana="#claim_type" resp="#paper">mechanism</span>
      <span xml:id="t4" from="#a60" to="#a61" type="phenomenon" ana="#phenomenon" resp="#paper">prefrontal parvalbumin interneuron control of working memory and cognitive flexibility</span>
      <span xml:id="t5" from="#a13" to="#a14" type="method" ana="#method" resp="#paper">behavioural-experiment<term>behavioural-experiment</term></span>
      <span xml:id="t6" from="#a92" to="#a93" type="mechanisms" ana="#mechanisms[0]" resp="#tagger">mechanisms<term>PV interneurons generate the fast network oscillations that synchronise prefrontal and coupled circuits, and that synchrony is what supports information processing during working memory — so blocking PV output removes it</term></span>
      <span xml:id="t7" from="#a79" to="#a80" type="mechanisms" ana="#mechanisms[1]" resp="#tagger">mechanisms<term>Loss of glutamatergic prefrontal afferent control dysregulates ventral brainstem dopamine neurons, raising subcortical dopamine and hence amphetamine sensitivity after PFC lesion</term></span>
      <span xml:id="t8" from="#a100" to="#a101" type="mechanisms" ana="#mechanisms[2]" resp="#tagger">mechanisms<term>A division of labour among GABAergic interneuron sub-populations means silencing only the PV class removes one specific circuit function, producing a cognitive-only deficit profile rather than the full lesion profile</term></span>
      <span xml:id="t9" from="#a17" to="#a19" type="mechanisms" ana="#mechanisms[3]" resp="#tagger" cert="1.0">tetanus toxin light chain is expressed only where Cre flips its reading frame, and it stops release by cleaving VAMP2</span>
      <span xml:id="t10" from="#a11" to="#a12" type="mechanisms" ana="#mechanisms[4]" resp="#tagger" cert="1.0">PV interneurons target the soma, proximal dendrites and axon initial segment of principal cells, which is why they can govern regional output</span>
      <span xml:id="t11" from="#a91" to="#a93" type="mechanisms" ana="#mechanisms[5]" resp="#tagger" cert="0.7">the proposed route from PV loss to cognitive deficit runs through network oscillations, which are thought to depend on fast-spiking interneurons</span>
      <span xml:id="t12" from="#a77" to="#a78" type="mechanisms" ana="#mechanisms[6]" resp="#tagger" cert="0.7">the route from prefrontal damage to amphetamine hypersensitivity runs through loss of cortical control over subcortical dopamine</span>
      <span xml:id="t13" from="#a9" to="#a10" type="mechanisms" ana="#mechanisms[7]" resp="#tagger" cert="0.6">impaired PV signalling may be where many separate genetic and environmental risks converge</span>
      <span xml:id="t14" from="#a119" to="#a120" type="limitations" ana="#limitations[0]" resp="#tagger">The two manipulations (viral silencing and lesion) were run as separate sequential experiments, so the four groups cannot be compared in a single factorial analysis.<note>what this limits: any direct comparison between the silencing and the lesion arms: THIS EXPERIMENTAL DESIGN PRECLUDES A DIRECT 2 x 2 STATISTICAL COMPARISON</note></span>
      <span xml:id="t15" from="#a25" to="#a26" type="limitations" ana="#limitations[1]" resp="#tagger">A small fraction of transgene expression fell in PV-negative cells, whose identity is inferred rather than established.<note>what this limits: the cell-type specificity claim: TRANSGENE-EXPRESSION IN PV-NEGATIVE CELLS WAS SCARCE (4.3%) AND LIKELY INCLUDES PVIS CONTAINING PV LEVELS BELOW DETECTION THRESHOLD - the identity of those cells is inferred, not established</note></span>
      <span xml:id="t16" from="#a114" to="#a115" type="limitations" ana="#limitations[2]" resp="#tagger">Viral expression was verified quantitatively in only one of the two water-maze cohorts.<note>what this limits: the water-maze expression data: ONLY COHORT 1 WAS QUANTITATIVELY ASSESSED (N = 10/17)</note></span>
      <span xml:id="t17" from="#a20" to="#a21" type="limitations" ana="#limitations[3]" resp="#tagger" cert="1.0">silencing covers over 75% of PV cells, not all of them, so a residual population remains active<note>what this limits: what &#x27;PV-silenced&#x27; means in every result: BILATERAL INFUSIONS OF AAV-FLEX-TeLC RESULTED IN EXPRESSION OF TeLC IN OVER 75% OF PVIs, so a residual population stays active</note></span>
      <span xml:id="t18" from="#a30" to="#a32" type="limitations" ana="#limitations[4]" resp="#tagger" cert="1.0">VAMP2 immunoreactivity was reduced but not abolished; completeness of the block is argued from a previous result in a different brain region<note>what this limits: the completeness of the transmission block: THE RESIDUAL VAMP2 IMMUNOREACTIVITY IS LIKELY DUE TO LOW AFFINITY RECOGNITION OF VAMP2 CLEAVAGE PRODUCTS, with completeness argued from a previous hippocampal result rather than measured here</note></span>
      <span xml:id="t19" from="#a25" to="#a26" type="limitations" ana="#limitations[5]" resp="#tagger" cert="1.0">4.3% of transgene expression was in PV-negative cells, which the authors read as PV below detection rather than off-target<note>duplicate of: limitations[1] · what this limits: the same scope as limitations[1], with the figure: 4.3% of transgene expression was in PV-negative cells, read by the authors as PV below detection rather than as off-target expression</note></span>
      <span xml:id="t20" from="#a113" to="#a116" type="limitations" ana="#limitations[6]" resp="#tagger" cert="1.0">in the water maze only one of two cohorts was quantitatively verified histologically; the rest was confirmed by eye<note>what this limits: the water-maze results specifically: ONLY COHORT 1 WAS QUANTITATIVELY ASSESSED (n = 10/17). FOR COHORT 2 AND ALL PFC-PV-GFP ANIMALS CORRECT VIRAL EXPRESSION WAS CONFIRMED VISUALLY</note></span>
      <span xml:id="t21" from="#a96" to="#a97" type="limitations" ana="#limitations[7]" resp="#tagger" cert="1.0">the reversal deficit after PV silencing is transient, so the manipulation delays rather than prevents relearning<note>what this limits: the reversal deficit, which is a delay rather than a prevention: THIS DEFICIT WAS TRANSIENT IN PFC-PV-TeLC ANIMALS, WHERE ALL MICE EVENTUALLY ACQUIRED THE NEW LOCATION</note></span>
      <span xml:id="t22" from="#a15" to="#a16" type="transfers" ana="#transfers[0]" resp="#tagger" cert="1.0">the tripartite positive/negative/cognitive symptom division, imported as a way of choosing which rodent assays to run</span>
      <span xml:id="t23" from="#a17" to="#a19" type="transfers" ana="#transfers[1]" resp="#tagger" cert="1.0">tetanus toxin light chain, used as a genetically targetable silencer of transmitter release</span>
      <span xml:id="t24" from="#a77" to="#a78" type="transfers" ana="#transfers[2]" resp="#tagger" cert="0.9">amphetamine-induced locomotion as a behavioural proxy for subcortical dopamine tone</span>
      <span xml:id="t25" from="#a117" to="#a118" type="controls" ana="#controls[0]" resp="#tagger" cert="0.85">the analysis carried out blind to the experimental group<note>eliminates: experimenter expectancy in a manual analysis · outcome (stated by the tagger, no quotation): held</note></span>
      <span xml:id="t26" from="#a121" to="#a122" type="controls" ana="#controls[1]" resp="#tagger" cert="0.85">the manual re-investigation also performed by an experimenter blind to the experimental group<note>eliminates: the blinding being lost at the second pass - the re-check is the step most likely to be done informally, and it was blinded too · outcome (stated by the tagger, no quotation): held</note></span>
      <span xml:id="t27" from="#a81" to="#a82" type="concepts" ana="#concepts[4]" resp="#paper">PFC<term>PFC</term></span>
      <span xml:id="t28" from="#a81" to="#a82" type="concepts" ana="#concepts[16]" resp="#paper">amphetamine<term>amphetamine</term></span>
      <span xml:id="t29" from="#a87" to="#a88" type="senses" ana="#senses[0]" resp="#tagger" cert="1.0">PFC dysfunction is used at two different grains here - a whole-region lesion and the loss of one interneuron class - and the paper&#x27;s point is that they are NOT the same manipulation</span>
      <span xml:id="t30" from="#a53" to="#a54" type="senses" ana="#senses[1]" resp="#tagger" cert="1.0">working memory in this paper spans three tasks with different demands: repeat investigation, spontaneous alternation, and a 60s delayed match-to-place</span>
      <span xml:id="t31" from="#a15" to="#a16" type="senses" ana="#senses[2]" resp="#tagger" cert="1.0">cognitive, negative and positive symptoms are used as ANIMAL CORRELATES of clinical categories, assigned by which behavioural assay was chosen</span>
      <span xml:id="t32" from="#a23" to="#a24" type="senses" ana="#senses[3]" resp="#tagger" cert="1.0">mouse PFC here means a block spanning prelimbic, infralimbic, cingulate and medial orbital cortex, treated as integrating what three separate human regions do</span>
      <span xml:id="t33" from="#a17" to="#a19" type="senses" ana="#senses[4]" resp="#tagger" cert="0.9">inactivation means blocked transmitter release with the cell alive, not cell death - the contrast case in the same paper kills the tissue</span>
      <span xml:id="t34" from="#a3" to="#a4" type="alternatives" ana="#alternatives.claim_type" resp="#tagger">claim_type: mechanism<note>a second reading reaching the same value. Recorded: mechanism — note: a second reading reaching the same value from a different sentence. Not applied - a person decides.</note></span>
      <span xml:id="t35" from="#a40" to="#a41" type="alternatives" ana="#alternatives.method" resp="#tagger">method: cell-type-selective synaptic silencing with Cre-dependent tetanus toxin light chain, compared against a titrated excitotoxic lesion of the same region, across a behavioural battery<note>a second reading DIFFERING from the recorded value. Recorded: behavioural-experiment — note: a second reading, verbatim-verified, disagreeing with the value on the record. Not applied - a person decides.</note></span>
      <span xml:id="t36" from="#a87" to="#a88" type="alternatives" ana="#alternatives.phenomenon" resp="#tagger">phenomenon: the behavioural syndrome produced by prefrontal dysfunction, split by which circuit element is removed<note>a second reading DIFFERING from the recorded value. Recorded: prefrontal parvalbumin interneuron control of working memory and cognitive flexibility — note: a second reading, verbatim-verified, disagreeing with the value on the record. Not applied - a person decides.</note></span>
      <span xml:id="t37" from="#a31" to="#a33" type="claim_relations" ana="#claim_relations[0]" resp="#tagger">builds-on → the authors&#x27; own earlier study of hippocampal parvalbumin interneurons using the same AAV-FLEX-TeLC construct (cited as ref. 26)</span>
      <span xml:id="t38" from="#a7" to="#a8" type="claim_relations" ana="#claim_relations[1]" resp="#tagger" cert="1.0">extends → post-mortem findings of reduced GAD67 and parvalbumin in schizophrenia</span>
      <span xml:id="t39" from="#a81" to="#a82" type="claim_relations" ana="#claim_relations[2]" resp="#tagger" cert="1.0">confirms → prior lesion work establishing PFC involvement in social behaviour and amphetamine sensitivity</span>
      <span xml:id="t40" from="#a105" to="#a106" type="claim_relations" ana="#claim_relations[3]" resp="#tagger" cert="1.0">qualifies → the view that PV interneuron pathology explains the breadth of prefrontal dysfunction in schizophrenia</span>
      <span xml:id="t41" from="#a98" to="#a99" type="claim_relations" ana="#claim_relations[4]" resp="#tagger" cert="0.9">supports → bicuculline studies in which total disinhibition of the PFC reproduced the full lesion-like profile</span>
      <span xml:id="t42" from="#a102" to="#a104" type="claim_relations" ana="#claim_relations[5]" resp="#tagger" cert="1.0">distinguishes-from → somatostatin interneurons, silenced the same way with no working memory effect<note>differs in: THE AXIS IS WHICH INTERNEURON POPULATION IS SILENCED, WITH THE MANIPULATION HELD IDENTICAL. &#x27;analogous tetanus toxin-based targeting of a different, somatostatin (Sst)-expressing, population of interneurons in the PFC.&#x27; Same toxin, same region, different cell class and no working-memory effect - so the result is attributable to the population rather than to the method, which is exactly what a single-population study cannot establish.</note></span>
      <span xml:id="t43" from="#a17" to="#a19" type="concept_edges" ana="#concept_edges[0]" resp="#tagger" cert="1.0">tetanus toxin light chain —causes→ VAMP2<note>strength of the relation: 1 · note: cleavage is the mechanism of the silencing, and the antibody against VAMP2 is also how coverage is checked
Audit 2026-09-28: DOUBTFUL - read against its full span and kept, but TeLC stops transmitter release BY CLEAVING VAMP2; &#x27;causes VAMP2&#x27; is loose.</note><term>tetanus toxin light chain</term><term>VAMP2</term></span>
      <span xml:id="t44" from="#a11" to="#a12" type="concept_edges" ana="#concept_edges[1]" resp="#tagger" cert="1.0">basket —is-a→ PVIs<note>strength of the relation: 1</note><term>basket</term><term>PVIs</term></span>
      <span xml:id="t45" from="#a11" to="#a12" type="concept_edges" ana="#concept_edges[2]" resp="#tagger" cert="1.0">chandelier cells —is-a→ PVIs<note>strength of the relation: 1</note><term>chandelier cells</term><term>PVIs</term></span>
      <span xml:id="t46" from="#a102" to="#a104" type="concept_edges" ana="#concept_edges[4]" resp="#tagger" cert="1.0">PVIs —contrasted-with→ somatostatin<note>strength of the relation: 1 · note: CRITERION: same toxin, same task, no working memory deficit - the cell-type specificity control</note><term>PVIs</term><term>somatostatin</term></span>
      <span xml:id="t47" from="#a60" to="#a61" type="concept_edges" ana="#concept_edges[5]" resp="#tagger" cert="1.0">PVIs —causes→ working memory<note>strength of the relation: 1</note><term>PVIs</term><term>working memory</term></span>
      <span xml:id="t48" from="#a65" to="#a66" type="concept_edges" ana="#concept_edges[6]" resp="#tagger" cert="0.9">PVIs —causes→ Behavioral flexibility<note>strength of the relation: 0.9 · note: the deficit is real but transient - PV silencing delays relearning where the lesion prevents it in a third of animals
Audit 2026-09-28: DOUBTFUL - read against its span and kept, but PV-silenced mice were slower at reversal; the edge lacks its direction and names PVIs for their silencing.</note><term>PVIs</term><term>Behavioral flexibility</term></span>
      <span xml:id="t49" from="#a75" to="#a76" type="concept_edges" ana="#concept_edges[7]" resp="#tagger" cert="1.0">PFC —causes→ social preference<note>strength of the relation: 1 · note: SIGN: the region is required and the PV population is not - this is the dissociation, stated
Audit 2026-09-28: DOUBTFUL - read against its full span and kept, but the span writes &#x27;social approach/avoidance behavior&#x27; and &#x27;novelty preference&#x27;, not &#x27;social preference&#x27;.</note><term>PFC</term><term>social preference</term></span>
      <span xml:id="t50" from="#a62" to="#a64" type="concept_edges" ana="#concept_edges[9]" resp="#tagger" cert="1.0">PFC —distinct-from→ spatial reference memory<note>strength of the relation: 1 · note: CRITERION: both perturbed groups acquired the platform normally, so the reversal deficit is not a learning deficit
Audit 2026-09-28: DOUBTFUL - read against its span and kept, but the span says spatial reference memory does NOT DEPEND on PFC; distinct-from paraphrases independence.</note><term>PFC</term><term>spatial reference memory</term></span>
      <span xml:id="t51" from="#a131" to="#a132" type="content_tags" ana="#content_tags.statistics[0]" resp="#tagger">t-test<term>t-test</term></span>
      <span xml:id="t52" from="#a133" to="#a134" type="content_tags" ana="#content_tags.statistics[1]" resp="#tagger">ANOVA<term>ANOVA</term></span>
      <span xml:id="t53" from="#a135" to="#a136" type="content_tags" ana="#content_tags.statistics[2]" resp="#tagger">chi-squared / Fisher&#x27;s exact test<term>chi-squared / Fisher&#x27;s exact test</term></span>
      <span xml:id="t54" from="#a137" to="#a138" type="content_tags" ana="#content_tags.statistics[3]" resp="#tagger">significance level (alpha)<term>significance level (alpha)</term></span>
      <span xml:id="t55" from="#a109" to="#a110" type="content_tags" ana="#content_tags.statistics[4]" resp="#tagger">spectral power analysis (Fast Fourier Transform)<term>spectral power analysis (Fast Fourier Transform)</term></span>
      <span xml:id="t56" from="#a27" to="#a29" type="content_tags" ana="#content_tags.statistics[5]" resp="#tagger" cert="0.9">t<term>t</term></span>
      <span xml:id="t57" from="#a62" to="#a64" type="content_tags" ana="#content_tags.statistics[6]" resp="#tagger" cert="0.8">day effect<term>day effect</term></span>
      <span xml:id="t58" from="#a107" to="#a108" type="content_tags" ana="#content_tags.statistics[7]" resp="#tagger" cert="1.0">Fast Fourier Transform<term>Fast Fourier Transform</term></span>
      <span xml:id="t59" from="#a87" to="#a88" type="content_tags" ana="#content_tags.findings[0]" resp="#tagger">Silencing PV interneurons in the prefrontal cortex produced deficits only in the cognitive domain, whereas non-selective PFC lesions disrupted behaviours mapping onto all three schizophrenia symptom categories.</span>
      <span xml:id="t60" from="#a48" to="#a49" type="content_tags" ana="#content_tags.findings[1]" resp="#tagger">Both PV-silenced and lesioned mice showed increased repeat investigations.</span>
      <span xml:id="t61" from="#a58" to="#a59" type="content_tags" ana="#content_tags.findings[2]" resp="#tagger">Spontaneous alternation in the Y-maze was reduced in both PV-silenced and lesioned mice relative to controls.</span>
      <span xml:id="t62" from="#a55" to="#a57" type="content_tags" ana="#content_tags.findings[3]" resp="#tagger">In the delayed match-to-place task control mice improved significantly on match trials while PV-silenced mice did not.</span>
      <span xml:id="t63" from="#a62" to="#a63" type="content_tags" ana="#content_tags.findings[4]" resp="#tagger">During initial water-maze training both PV-silenced and lesioned mice learned the platform location as well as their controls.</span>
      <span xml:id="t64" from="#a67" to="#a68" type="content_tags" ana="#content_tags.findings[5]" resp="#tagger">Whereas PV-silenced mice met the reversal criterion upon overtraining, more than 30% of lesioned mice failed to.</span>
      <span xml:id="t65" from="#a71" to="#a72" type="content_tags" ana="#content_tags.findings[6]" resp="#tagger">Lesioned mice failed to discriminate a familiar from an unfamiliar conspecific.</span>
      <span xml:id="t66" from="#a73" to="#a74" type="content_tags" ana="#content_tags.findings[7]" resp="#tagger">Amphetamine produced hypersensitivity — higher peak locomotion and slower decay — in lesioned mice only.</span>
      <span xml:id="t67" from="#a85" to="#a86" type="content_tags" ana="#content_tags.findings[8]" resp="#tagger">PV interneurons do not seem to be required for the PFC&#x27;s regulation of amphetamine sensitivity.</span>
      <span xml:id="t68" from="#a35" to="#a36" type="content_tags" ana="#content_tags.findings[9]" resp="#tagger">Local field potential recordings showed no sign of enhanced synchronous activity after PV-cell silencing.</span>
      <span xml:id="t69" from="#a103" to="#a104" type="content_tags" ana="#content_tags.findings[10]" resp="#tagger">Applying the same tetanus-toxin silencing to somatostatin-expressing interneurons left working memory intact, showing the deficit is specific to the PV population.</span>
      <span xml:id="t70" from="#a20" to="#a22" type="content_tags" ana="#content_tags.findings[11]" resp="#tagger">The viral strategy expressed the toxin in over 75% of PV interneurons in prelimbic and infralimbic cortex.</span>
      <span xml:id="t71" from="#a27" to="#a28" type="content_tags" ana="#content_tags.findings[12]" resp="#tagger">VAMP2 immunoreactivity was strongly reduced in toxin-positive terminals compared with GFP-positive terminals, confirming the toxin cleaved its synaptic target.</span>
      <span xml:id="t72" from="#a48" to="#a50" type="content_tags" ana="#content_tags.findings[13]" resp="#tagger" cert="1.0">both PV silencing and whole-region lesion increased repeat investigations in the hole-board test</span>
      <span xml:id="t73" from="#a51" to="#a52" type="content_tags" ana="#content_tags.findings[14]" resp="#tagger" cert="1.0">spontaneous alternation fell from about 70% to about 57% after PV silencing</span>
      <span xml:id="t74" from="#a55" to="#a56" type="content_tags" ana="#content_tags.findings[15]" resp="#tagger" cert="1.0">PV-silenced mice failed to improve in delayed match-to-place while controls did</span>
      <span xml:id="t75" from="#a65" to="#a66" type="content_tags" ana="#content_tags.findings[16]" resp="#tagger" cert="1.0">reversal learning was slowed by both manipulations, significantly so for PV silencing</span>
      <span xml:id="t76" from="#a67" to="#a68" type="content_tags" ana="#content_tags.findings[17]" resp="#tagger" cert="1.0">the reversal deficit differed in severity: PV-silenced mice reached criterion with overtraining, over 30% of lesioned mice never did</span>
      <span xml:id="t77" from="#a69" to="#a70" type="content_tags" ana="#content_tags.findings[18]" resp="#tagger" cert="1.0">lesioned mice showed strongly reduced interaction with a conspecific, while PV-silenced mice interacted like their controls</span>
      <span xml:id="t78" from="#a83" to="#a84" type="content_tags" ana="#content_tags.findings[19]" resp="#tagger" cert="1.0">PV-silenced mice did not differ from controls in their response to amphetamine</span>
      <span xml:id="t79" from="#a87" to="#a88" type="content_tags" ana="#content_tags.findings[20]" resp="#tagger" cert="1.0">the whole-region lesion produced deficits in all three symptom domains and PV silencing only in the cognitive one</span>
      <span xml:id="t80" from="#a34" to="#a37" type="content_tags" ana="#content_tags.findings[21]" resp="#tagger" cert="1.0">CONTROL NULL: local field potentials showed no enhanced synchrony, so the deficits are not seizure activity from lost inhibition</span>
      <span xml:id="t81" from="#a42" to="#a43" type="content_tags" ana="#content_tags.findings[22]" resp="#tagger" cert="1.0">CONTROL NULL: neither manipulation altered locomotion or anxiety-related behaviour at baseline</span>
      <span xml:id="t82" from="#a46" to="#a47" type="content_tags" ana="#content_tags.findings[23]" resp="#tagger" cert="1.0">CONTROL NULL: nose-poke counts were alike across groups, so the working memory deficit is not reduced exploration</span>
      <span xml:id="t83" from="#a62" to="#a64" type="content_tags" ana="#content_tags.findings[24]" resp="#tagger" cert="1.0">CONTROL NULL: initial platform acquisition was normal in both perturbed groups, indicating that spatial reference memory per se does not depend on the PFC</span>
      <span xml:id="t84" from="#a102" to="#a104" type="content_tags" ana="#content_tags.findings[25]" resp="#tagger" cert="1.0">CONTROL NULL: silencing somatostatin interneurons the same way left working memory intact</span>
      <span xml:id="t85" from="#a71" to="#a72" type="content_tags" ana="#content_tags.findings[26]" resp="#tagger" cert="1.0">lesioned mice failed to tell a familiar conspecific from an unfamiliar one</span>
      <span xml:id="t86" from="#a75" to="#a76" type="content_tags" ana="#content_tags.findings[27]" resp="#tagger" cert="0.9">social recognition and approach depend on PFC circuitry, but PV interneurons do not seem to be a crucial component of it</span>
      <span xml:id="t87" from="#a89" to="#a90" type="content_tags" ana="#content_tags.definitions[0]" resp="#tagger">working memory<term>working memory</term></span>
      <span xml:id="t88" from="#a94" to="#a95" type="content_tags" ana="#content_tags.definitions[1]" resp="#tagger">behavioral flexibility<term>behavioral flexibility</term></span>
      <span xml:id="t89" from="#a18" to="#a19" type="content_tags" ana="#content_tags.definitions[2]" resp="#tagger">tetanus toxin light chain (TeLC)<term>tetanus toxin light chain (TeLC)</term></span>
      <span xml:id="t90" from="#a125" to="#a126" type="content_tags" ana="#content_tags.definitions[3]" resp="#tagger">complete alternation<term>complete alternation</term></span>
      <span xml:id="t91" from="#a123" to="#a124" type="content_tags" ana="#content_tags.definitions[4]" resp="#tagger">perfect trial<term>perfect trial</term></span>
      <span xml:id="t92" from="#a129" to="#a130" type="content_tags" ana="#content_tags.definitions[5]" resp="#tagger">discrimination index<term>discrimination index</term></span>
      <span xml:id="t93" from="#a89" to="#a90" type="content_tags" ana="#content_tags.definitions[6]" resp="#tagger" cert="1.0">working memory<term>working memory</term></span>
      <span xml:id="t94" from="#a94" to="#a95" type="content_tags" ana="#content_tags.definitions[7]" resp="#tagger" cert="1.0">Behavioral flexibility<term>Behavioral flexibility</term></span>
      <span xml:id="t95" from="#a17" to="#a19" type="content_tags" ana="#content_tags.definitions[8]" resp="#tagger" cert="1.0">tetanus toxin light chain<term>tetanus toxin light chain</term></span>
      <span xml:id="t96" from="#a53" to="#a54" type="content_tags" ana="#content_tags.definitions[9]" resp="#tagger" cert="1.0">match-to-place<term>match-to-place</term></span>
      <span xml:id="t97" from="#a44" to="#a45" type="content_tags" ana="#content_tags.definitions[10]" resp="#tagger" cert="1.0">hole-board<term>hole-board</term></span>
      <span xml:id="t98" from="#a38" to="#a39" type="content_tags" ana="#content_tags.variables[1]" resp="#tagger">non-cell-type-specific PFC lesions<term>non-cell-type-specific PFC lesions</term></span>
      <span xml:id="t99" from="#a127" to="#a128" type="content_tags" ana="#content_tags.variables[2]" resp="#tagger">percentage alternation<term>percentage alternation</term></span>
      <span xml:id="t100" from="#a62" to="#a64" type="content_tags" ana="#content_tags.variables[6]" resp="#tagger" cert="1.0">path length<term>path length</term></span>
      <span xml:id="t101" from="#a51" to="#a52" type="content_tags" ana="#content_tags.variables[7]" resp="#tagger" cert="1.0">spontaneous alternation<term>spontaneous alternation</term></span>
      <span xml:id="t102" from="#a48" to="#a50" type="content_tags" ana="#content_tags.variables[8]" resp="#tagger" cert="1.0">repeat investigations<term>repeat investigations</term></span>
      <span xml:id="t103" from="#a81" to="#a82" type="content_tags" ana="#content_tags.variables[9]" resp="#tagger" cert="1.0">peak activity<term>peak activity</term></span>
      <span xml:id="t104" from="#a20" to="#a22" type="content_tags" ana="#content_tags.quantities[0]" resp="#tagger">over 75% — proportion of prelimbic and infralimbic PV interneurons expressing the tetanus toxin transgene</span>
      <span xml:id="t105" from="#a25" to="#a26" type="content_tags" ana="#content_tags.quantities[1]" resp="#tagger">4.3% — off-target transgene expression in PV-negative cells</span>
      <span xml:id="t106" from="#a67" to="#a68" type="content_tags" ana="#content_tags.quantities[2]" resp="#tagger">more than 30% — share of lesioned mice that never reached the reversal-learning criterion, versus none of the PV-silenced mice</span>
      <span xml:id="t107" from="#a20" to="#a21" type="content_tags" ana="#content_tags.quantities[3]" resp="#tagger" cert="1.0">over 75% — share of PV interneurons expressing the silencer in prelimbic and infralimbic cortex</span>
      <span xml:id="t108" from="#a25" to="#a26" type="content_tags" ana="#content_tags.quantities[4]" resp="#tagger" cert="1.0">4.3% — transgene expression in PV-negative cells, read by the authors as PV below detection</span>
      <span xml:id="t109" from="#a51" to="#a52" type="content_tags" ana="#content_tags.quantities[5]" resp="#tagger" cert="0.85">70.0% and 74.3% vs 56.9% and 60.0% — Y-maze alternation in the two control groups against the two perturbed groups</span>
      <span xml:id="t110" from="#a67" to="#a68" type="content_tags" ana="#content_tags.quantities[6]" resp="#tagger" cert="1.0">more than 30% — lesioned mice that never reached reversal criterion, against none of the PV-silenced</span>
      <span xml:id="t111" from="#a111" to="#a112" type="content_tags" ana="#content_tags.quantities[7]" resp="#tagger" cert="1.0">9344 — PV-positive cells counted for the coverage estimate</span>
      <span xml:id="t112" from="#a53" to="#a54" type="content_tags" ana="#content_tags.quantities[8]" resp="#tagger" cert="1.0">60s — delay in the match-to-place test of trial-unique memory</span>
    </spanGrp>
  </standOff>
  <text>
    <body>
        <p><anchor xml:id="a0"/>Parvalbumin-positive interneurons of the prefrontal cortex support working memory and cognitive flexibility</p>
        <p>Andrew J Murray   Andrew J Murray</p>
        <p>1 Institute of Medical Sciences, University of Aberdeen, Foresterhill, Aberdeen, AB25 2ZD, United Kingdom</p>
        <p>2 Department of Biochemistry and Molecular Biophysics, Columbia University, New York, NY 10032, USA</p>
        <p>Find articles by Andrew J Murray</p>
        <p>1, 2, * , Marta U Woloszynowska-Fraser   Marta U Woloszynowska-Fraser</p>
        <p>1 Institute of Medical Sciences, University of Aberdeen, Foresterhill, Aberdeen, AB25 2ZD, United Kingdom</p>
        <p>Find articles by Marta U Woloszynowska-Fraser</p>
        <p>1, * , Laura Ansel-Bollepalli   Laura Ansel-Bollepalli</p>
        <p>1 Institute of Medical Sciences, University of Aberdeen, Foresterhill, Aberdeen, AB25 2ZD, United Kingdom</p>
        <p>3 Institute of Physiology, Christian Albrechts University Kiel, 24098 Kiel, Germany</p>
        <p>Find articles by Laura Ansel-Bollepalli</p>
        <p>1, 3 , Katy L H Cole   Katy L H Cole</p>
        <p>1 Institute of Medical Sciences, University of Aberdeen, Foresterhill, Aberdeen, AB25 2ZD, United Kingdom</p>
        <p>Find articles by Katy L H Cole</p>
        <p>1 , Angelica Foggetti   Angelica Foggetti</p>
        <p>1 Institute of Medical Sciences, University of Aberdeen, Foresterhill, Aberdeen, AB25 2ZD, United Kingdom</p>
        <p>3 Institute of Physiology, Christian Albrechts University Kiel, 24098 Kiel, Germany</p>
        <p>Find articles by Angelica Foggetti</p>
        <p>1, 3 , Barry Crouch   Barry Crouch</p>
        <p>1 Institute of Medical Sciences, University of Aberdeen, Foresterhill, Aberdeen, AB25 2ZD, United Kingdom</p>
        <p>Find articles by Barry Crouch</p>
        <p>1 , Gernot Riedel   Gernot Riedel</p>
        <p>1 Institute of Medical Sciences, University of Aberdeen, Foresterhill, Aberdeen, AB25 2ZD, United Kingdom</p>
        <p>Find articles by Gernot Riedel</p>
        <p>1, a , Peer Wulff   Peer Wulff</p>
        <p>1 Institute of Medical Sciences, University of Aberdeen, Foresterhill, Aberdeen, AB25 2ZD, United Kingdom</p>
        <p>3 Institute of Physiology, Christian Albrechts University Kiel, 24098 Kiel, Germany</p>
        <p>Find articles by Peer Wulff</p>
        <p>1, 3, b</p>
        <p>Author information</p>
        <p>Article notes</p>
        <p>Copyright and License information</p>
        <p>1 Institute of Medical Sciences, University of Aberdeen, Foresterhill, Aberdeen, AB25 2ZD, United Kingdom</p>
        <p>2 Department of Biochemistry and Molecular Biophysics, Columbia University, New York, NY 10032, USA</p>
        <p>3 Institute of Physiology, Christian Albrechts University Kiel, 24098 Kiel, Germany</p>
        <p>a Email: g.riedel@abdn.ac.uk</p>
        <p>b Email: p.wulff@physiologie.uni-kiel.de</p>
        <p>* These authors contributed equally to this work.</p>
        <p>Received 2015 Jun 26; Accepted 2015 Oct 20; Collection date 2015.</p>
        <p>Copyright © 2015, Macmillan Publishers Limited</p>
        <p>This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/</p>
        <p>PMC Copyright notice</p>
        <p>PMCID: PMC4660359  PMID: 26608841</p>
        <p>Abstract</p>
        <p>Dysfunction of parvalbumin (PV)-positive GABAergic interneurons (PVIs) within the prefrontal cortex (PFC) has been implicated in schizophrenia pathology. It is however unclear, how impaired signaling of these neurons may contribute to PFC dysfunction. To identify how PVIs contribute to PFC-dependent behaviors we inactivated PVIs in the PFC in mice using region- and cell-type-selective expression of tetanus toxin light chain (TeLC) and compared the functional consequences of this manipulation with non-cell-type-selective perturbations of the same circuitry. <anchor xml:id="a1"/>By sampling for behavioral alterations that map onto distinct symptom categories in schizophrenia, we show that dysfunction of PVI signaling in the PFC specifically produces deficits in the cognitive domain, but does not give rise to PFC-dependent correlates of negative or positive symptoms.<anchor xml:id="a2"/> <anchor xml:id="a3"/>Our results suggest that distinct aspects of the complex symptomatology of PFC dysfunction in schizophrenia can be attributed to specific prefrontal circuit elements.<anchor xml:id="a4"/></p>
        <p>Functional imaging studies have suggested that dysfunction of the prefrontal cortex (PFC) underlies a multitude of deficits associated with schizophrenia, comprising positive (e.g. delusions and hallucinations), negative (e.g. emotional and social dysfunction) and cognitive (e.g. impairments in working memory and cognitive flexibility) symptoms 1 , 2 , 3 , 4 , 5 . <anchor xml:id="a5"/>Although these disturbances all appear to involve PFC dysfunction, it is unclear whether specific circuit elements within the PFC contribute differentially to symptom complexity.<anchor xml:id="a6"/></p>
        <p>Post-mortem studies of schizophrenia patients have suggested that PFC dysfunction involves alterations of the inhibitory circuitry of the PFC 6 , 7 , 8 . <anchor xml:id="a7"/>In particular reduced mRNA levels of the 67 kD isoform of the GABA synthesizing enzyme glutamic acid decarboxylase (GAD67) have been consistently reported 9 , 10 , 11 , 12 , 13 . These changes seem to dominantly affect a subclass of GABAergic interneurons, that expresses the calcium-binding protein PV, which itself shows reduced expression in schizophrenia<anchor xml:id="a8"/> 11 , 13 , 14 , 15 , 16 . In addition, genes associated with increased susceptibility to schizophrenia like DISC1, NRG1/ERBB4 or dysbindin, play crucial roles for circuit integration and function particularly of PVIs in rodents 17 , 18 , 19 , 20 , 21 . PVIs are also preferentially damaged by drugs of abuse such as phencyclidine and ketamine, which produce schizophrenia-like symptoms 22 , 23 . <anchor xml:id="a9"/>Accordingly impaired signaling of PVIs may form a common endpoint for different genetic and environmental factors leading to PFC malfunction and schizophrenia-associated deficits<anchor xml:id="a10"/> 19 , 24 .</p>
        <p><anchor xml:id="a11"/>In the isocortex PVIs mainly comprise basket and chandelier cells, which control network activity by targeting the soma and proximal dendrites or the axon initial segment of principal cells, respectively<anchor xml:id="a12"/> 25 . They are therefore well placed to exert rigorous control over PFC activity. However, little is known about the behavioral functions of these interneurons within the PFC circuitry.</p>
        <p><anchor xml:id="a13"/>To directly test how chronic impairment of PVI signaling affects PFC-dependent behavior, we selectively blocked output from PVIs in the mouse PFC by cell-type- and region-selective expression of tetanus toxin light chain (TeLC).<anchor xml:id="a14"/> <anchor xml:id="a15"/>To distinguish PFC-dependent behaviors which require intact PVI signaling from those that do not, we compared PVI-selective interference with non-cell-type-selective perturbations of the same circuitry in behavioral assays that were chosen to detect alterations that map onto symptom categories (positive, negative, cognitive) in schizophrenia.<anchor xml:id="a16"/></p>
        <p>Results</p>
        <p>PV-cell-specific disruption of synaptic transmission in the PFC</p>
        <p>We made stereotaxic injections of adeno-associated viruses carrying a GFP-tagged TeLC (or GFP alone as control, Fig. S1 ) reading frame inverted (3’ to 5’) in a flip-excision cassette (AAV-FLEX-TeLC and AAV-FLEX-GFP) 26 into the PFC of PV-Cre knock-in mice 27 . <anchor xml:id="a17"/>As Cre-recombinase is required to flip the reading frame into the correct orientation, transcription of TeLC can only occur in PVIs 26 . <anchor xml:id="a18"/>Once expressed, TeLC efficiently stops transmitter release by cleaving VAMP2, a protein required for synaptic vesicle docking<anchor xml:id="a19"/> 26 ( Fig. 1A ). <anchor xml:id="a20"/>Bilateral infusions of AAV-FLEX-TeLC resulted in expression of TeLC in over 75% of PVIs in prelimbic and infralimbic regions of the PFC<anchor xml:id="a21"/> ( Fig. 1C,D,F ).<anchor xml:id="a22"/> <anchor xml:id="a23"/>Additionally, TeLC expression was found in the cingulate and medial orbital cortices, demonstrating functional removal of PVIs across an area of mouse PFC thought to integrate functions of the dorsolateral, medial and orbital PFC in humans<anchor xml:id="a24"/> 28 , 29 , 30 . <anchor xml:id="a25"/>Transgene-expression in PV-negative cells was scarce (4.3%) and likely includes PVIs containing PV levels below detection threshold.<anchor xml:id="a26"/> Similar results were obtained for control AAV-FLEX-GFP injections (PFC-PV-GFP mice, data not shown). <anchor xml:id="a27"/>As expected, immunoreactivity for VAMP2 was strongly reduced in TeLC-positive terminals of PFC-PV-TeLC mice when compared with GFP-positive terminals of PFC-PV-GFP mice<anchor xml:id="a28"/> ( p  &lt; 0.0001; t  = 22.2; n = 4 animals per group; Fig. 1G ).<anchor xml:id="a29"/> <anchor xml:id="a30"/>The residual VAMP2 immunoreactivity is likely due to low affinity recognition of VAMP2 cleavage products by the antibody 31 . <anchor xml:id="a31"/>However, using the same AAV-FLEX-TeLC we have previously shown that transmission of hippocampal PVIs was fully abolished 10 days after virus injection despite residual VAMP2 immunoreactivity<anchor xml:id="a32"/> 26 .<anchor xml:id="a33"/> <anchor xml:id="a34"/>In principle, loss of PVI-mediated inhibition could induce hyper-activity in pyramidal cells and induce ictal discharges in the PFC, which in turn could complicate the interpretation of behavioral data. <anchor xml:id="a35"/>However, local field potential (LFP) recordings from PFC showed no indication of enhanced synchronous activity in PFC-PV-TeLC mice.<anchor xml:id="a36"/> PFC-PV-TeLC and PFC-PV-GFP mice displayed similar absolute power at different spectral frequency bands<anchor xml:id="a37"/> ( Fig. S2 ). <anchor xml:id="a38"/>In a second set of experiments we also made non-cell-type-specific PFC lesions, which have previously been used to investigate the behavioral role of the PFC, by injection of the fiber-sparing neurotoxin ibotenic acid<anchor xml:id="a39"/> 32 , 33 , 34 , 35 , 36 , 37 (or saline as control; PFC-Lesion and PFC-Saline mice; Fig. 1B,E,H ). <anchor xml:id="a40"/>We reasoned that this approach would confirm the PFC-dependence of our behavioral tests and that qualitative comparison of the behavioral deficits between PV-cell-selective and non-cell-type-selective circuit lesions would allow us to dissociate general PFC functions from those that specifically involve PVIs.<anchor xml:id="a41"/> To produce perturbations of comparable location and extent we titrated ibotenic acid injections according to viral spread.</p>
        <p>Figure 1. Cell-type-selective and general inactivation in the prefrontal cortex.</p>
        <p>Open in a new tab</p>
        <p>( A ) Injection of AAV-FLEX-TeLC into the PFC selectively blocks synaptic transmission in PVIs (grey shade in circuit cartoon) by cleaving VAMP2. Transmission in all other neurons remains intact. ( B ) Injection of ibotenic acid into the PFC causes general disruption of neuronal circuitry (grey shade). ( C ) Schematic of AAV spread in the mPFC of AAV-FLEX-TeLC-injected PV-Cre animals showing minimum (all animals &gt;50% infected PVIs) and maximum (&gt;50% infected PVIs only in most affected animals) infection area. ( D ) Immunohistochemistry illustrating co-localization of TeLC-GFP and PV in the mPFC ( E ), Schematic showing minimum (common to all animals) and maximum (in most affected animals) extent of ibotenic acid lesion in the mPFC. ( F ) Percentage of TeLC-GFP-expressing PVIs in subregions of the PFC. ( G ) Quantification of VAMP2 immunofluorescence intensity shows a substantial reduction in GFP-TeLC + /vGAT + puncta in PFC-PV-TeLC animals compared with GFP + /vGAT + puncta in PFC-PV-GFP animals. ( H ) Percentage of lesioned area in subfields of the PFC after ibotenic acid injection. PrL Prelimbic cortex; IL Infralimbic cortex; M2 Secondary motor cortex; CgL Cingulate; MO Medial orbital cortex. Scale bar in D = 20 µm. Data are mean ± s.e.m. ***p &lt; 0.001.</p>
        <p>PVIs in the PFC are required for spatial working memory</p>
        <p><anchor xml:id="a42"/>Neither PFC-PV-TeLC nor PFC-Lesion mice showed obvious neurological deficits or alterations in locomotion and anxiety-related behavior<anchor xml:id="a43"/> ( Fig. 2A-D ). As deficits in working memory are a dominant cognitive symptom in both schizophrenia and PFC lesions 4 , 35 , 38 , 39 we investigated the involvement of PVIs in the production of working memory. <anchor xml:id="a44"/>We implemented a hole-board-based working memory test by analyzing repeat investigations of previously explored holes.<anchor xml:id="a45"/> <anchor xml:id="a46"/>Although all groups of mice showed similar overall levels of nose pokes ( Fig. 2E,F ), indicating similar exploratory activity<anchor xml:id="a47"/>, <anchor xml:id="a48"/>both PFC-PV-TeLC and PFC-Lesion animals showed increased levels of repeat investigations<anchor xml:id="a49"/> (PFC-PV-TeLC vs. PFC-PV-GFP, p  = 0.04; t  = 1.97; PFC-Lesion vs. PFC-Saline, p  = 0.04; t  = 1.98)<anchor xml:id="a50"/> ( Fig. 3A,B ). <anchor xml:id="a51"/>This deficit was confirmed in a spontaneous alternation task in the Y-maze, where alternation levels were high in PFC-PV-GFP and PFC-Saline animals (70.0 ± 3.0% and 74.3 ± 4.1% respectively), but significantly lower in PFC-PV-TeLC and PFC-Lesion animals (56.9 ± 2.7% and 60.0 ± 2.3% respectively)<anchor xml:id="a52"/> ( Fig. 3C,D ). Both reinvestigation and spontaneous alternation probe a spontaneous on-line processing of information. To assess whether PVIs also contribute to temporally expanded forms of working memory, which are known to be impaired after PFC lesions 40 , 41 , <anchor xml:id="a53"/>we used a delayed (60s) match-to-place test in a Y-maze configuration in the water maze, where the percentage of correct responses in match trials represents trial unique short-term memory<anchor xml:id="a54"/> 26 . <anchor xml:id="a55"/>Whereas PFC-PV-GFP animals showed significant improvement in match trials, PFC-PV-TeLC animals did not<anchor xml:id="a56"/> ( Fig. 3E ).<anchor xml:id="a57"/></p>
        <p>Figure 2. Neither PFC-PV-TeLC nor PFC-Lesion animals showed alterations during baseline behavioral assessment.</p>
        <p>Open in a new tab</p>
        <p>Analysis of path length in the open field for ( A ), PFC-PV-GFP (n = 8) and PFC-PV-TeLC (n = 10) and ( B ), PFC-Saline (n = 9) and PFC-Lesion (n = 13) animals suggests normal baseline motor activity. ( C,D ) Time spent in the centre of an open field arena indicates no alterations in anxiety-related thigmotaxis. ( E,F ) The number of nose pokes during exploration of a hole-board arena is similar in all groups of mice indicating normal exploratory activity. Data are mean ± s.e.m.</p>
        <p>Figure 3. Working memory is impaired in PFC-Lesion and PFC-PV-TeLC animals.</p>
        <p>Open in a new tab</p>
        <p>( A ) PFC-PV-TeLC (n = 10) animals make significantly more repeat investigations in the hole-board test than PFC-PV-GFP (n = 8) and ( B ), PFC-Lesion (n = 13) mice make significantly more repeat investigations than PFC-Saline (n = 9) animals. <anchor xml:id="a58"/>( C ) In the same cohorts of mice spontaneous alternation in a Y-maze is reduced in PFC-PV-TeLC animals and in ( D ), PFC-Lesion animals compared to respective controls.<anchor xml:id="a59"/> ( E ) The same PFC-PV-TeLC and PFC-PV-GFP mice were subjected to a match to place protocol in the water Y-maze. PFC-PV-GFP animals are able to retain the platform position during the 1 minute delay period, whereas PFC-PV-TeLC animals are not. Data are mean ± s.e.m. * P  &lt; 0.05.</p>
        <p><anchor xml:id="a60"/>Thus various modalities of PFC-dependent working memory critically depend on PVI integrity.<anchor xml:id="a61"/></p>
        <p>Cognitive flexibility depends on prefrontal PVIs</p>
        <p>Cognitive flexibility is impaired in schizophrenia and after PFC lesion 41 , 42 , 43 , 44 . We investigated the relevance of prefrontal PVIs for cognitive flexibility in a reversal learning task in the water maze 36 , 37 . After initial spatial training (5 days, 4 trials/day) the platform was re-located to the opposite quadrant and mice underwent another 4 days (4 trials/day) of reversal training. <anchor xml:id="a62"/>During initial training PFC-PV-TeLC and PFC-Lesion mice learned the platform location as well as their respective controls as indicated by the reduction in path length<anchor xml:id="a63"/> (PFC-PV-TeLC/PFC-PV-GFP, day effect: F(4,120) = 45; p &lt; 0.0001, no effect with group as factor: F’s &lt; 1; PFC-Lesion/PFC-Saline, day effect: F(4,80) = 28; p &lt; 0.0001; no effect with group as factor: F’s &lt; 1) ( Fig. 4A,B ; see also Fig. 5 ) and the amount of time spent in the target quadrant during probe trials ( t’s  &lt; 1.4) ( Fig. 4 insets in A,B), indicating that spatial reference memory per se does not depend on the PFC<anchor xml:id="a64"/> 35 , 36 . <anchor xml:id="a65"/>In contrast, during reversal, PFC-PV-TeLC and PFC-Lesion mice needed more time to learn the new platform location although this was only significant for PFC-PV-TeLC mice (PFC-PV-TeLC vs. PFC-PV-GFP, day effect F(3,84) = 24; p &lt; 0.001; group effect F(4,84) = 8.8; p  = 0.006; and PFC-Lesion vs. PFC-Saline, F(3,60) = 2.1; p  = 0.16)<anchor xml:id="a66"/> ( Fig. 4C–F ). The deficit was transient as PFC-PV-TeLC mice performed as well as controls in the probe trial after over-training (t’s &lt; 1.1) ( Fig. 4 insets in C,D). We confirmed these deficits by analyzing two additional parameters. 1) The number of trials to attain floor level (4m path length, derived from Fig. 4 ) in two consecutive trials was not different between PFC-PV-TeLC or PFC-Lesion groups and their controls ( Fig. 5A,B ; t’s &lt; 1.4) during initial training, but was significantly higher in reversal trials ( Fig. 5A,B , t’s &gt; 1.7; p ’s ≤ 0.05). 2) We established the percentage of subjects meeting criterion (4m path length) for each trial during both training phases ( Fig. 5C–F ). During initial training we detected small differences between PFC-PV-TeLC or PFC-Lesion animals and their respective controls (a mild delay or acceleration in learning, respectively; Fig. 5C,D ). However, all subjects met criterion at completion of acquisition. During reversal both PFC-PV-TeLC and PFC-Lesion mice showed a deficit in learning the new platform location ( Fig. 5E,F ). <anchor xml:id="a67"/>However, whereas PFC-PV-TeLC mice met reversal criterion upon overtraining, more than 30% of PFC-Lesion mice failed to do so.<anchor xml:id="a68"/> These results suggest that PVIs contribute to prefrontal operations involved in the inhibition of previously learned responses.</p>
        <p>Figure 4. PFC-PV-TeLC and PFC-Lesion animals show impaired reversal learning.</p>
        <p>Open in a new tab</p>
        <p>Both PFC-PV-GFP (n = 15) and PFC-PV-TeLC (n = 17) ( A ) and PFC-Saline (n = 9) and PFC-Lesion (n = 13) animals ( B ) learn the location of the hidden platform in an open field water maze as indicated by 1) the reduction in path length to platform over the 5 day training period and 2) the amount of time spent in the target quadrant in a probe trial after training (insets). ( C ) PFC-PV-TeLC and ( D ), PFC-Lesion animals show a deficit in reversal learning as indicated by a delay in path length reduction during 4 days of reversal training (R1-4). All groups spent significantly more time in the new target quadrant in a probe trial after reversal learning (insets in C and D ). ( E,F ) Example traces of path taken by PFC-PV-GFP ( E , green), PFC-PV-TeLC (E, blue), PFC-Saline ( F , grey) and PFC-Lesion ( F , red) animals on the third day of reversal training. The original platform location is indicated as a hollow circle, the new platform location as filled circle. Note the increased length around the original platform location of PFC-PV-TeLC and PFC-Lesion animals compared to respective controls. Data are mean ± s.e.m.</p>
        <p>Figure 5. Criterion analysis confirms deficits in PFC-PV-TeLC and PFC-Lesion animals during reversal learning.</p>
        <p>Open in a new tab</p>
        <p>The average number of trials to criterion for PFC-PV-TeLC (blue) ( A ) and for PFC-Lesion (red) animals ( B ) was similar to respective controls (green and grey) during acquisition (left) but significantly different during reversal (right) learning. ( C,D ) During initial water maze training PFC-PV-TeLC ( C ; n = 17) and PFC-Lesion ( D ); n = 13) animals show small differences when compared to their respective controls (n = 15 and 9), but all animals acquire the task to the same standard. ( E,F ) After re-location of the platform both PFC-PV-TeLC ( E ) and PFC-Lesion ( F ) animals are significantly impaired at learning the new platform location. Data are mean ± s.e.m. *P &lt; 0.05; ***p &lt; 0.001.</p>
        <p>PVIs are dispensable for PFC-dependent behavior in a social preference test</p>
        <p>Impairments in social function are common after prefrontal lesions and a component of the negative symptomatology in schizophrenia 2 , 45 , 46 . Similarly, interference with PFC function in rodents has been shown to reduce social interaction 47 , 48 . We tested PFC-PV-TeLC, PFC-Lesion and control animals for sociability and social recognition in a 3-chamber social preference test 49 . <anchor xml:id="a69"/>During sociability testing PFC-Lesion animals showed strongly reduced interaction with the conspecific animal ( p  = 0.003; t = 3.57) ( Fig. 6B ). However, PFC-PV-TeLC mice displayed similar levels of social interaction as PFC-PV-GFP control animals<anchor xml:id="a70"/> ( p  = 0.15; t = 1.59) ( Fig. 6A ). A similar pattern evolved in the second phase, where both control groups and PFC-PV-TeLC mice spent significantly more time with the unfamiliar than with the familiar animal ( p  = 0.003; t  = 3.57 for PFC-PV-TeLC; p  = 0.04; t  = 1.97 for PFC-PV-GFP; p  = 0.04; t = 2.00 for PFC-Saline), indicating intact social memory and a preference for social novelty ( Fig. 6C,D ). <anchor xml:id="a71"/>In contrast PFC-Lesion animals did not discriminate between familiar and unfamiliar mice<anchor xml:id="a72"/> ( p  = 0.3; t &lt; 1) ( Fig. 6D ).</p>
        <p>Figure 6. PFC-Lesion but not PFC-PV-TeLC mice show impaired social behavior and amphetamine hypersensitivity.</p>
        <p>Open in a new tab</p>
        <p>( A,B ) Quantification of time spent interacting with a conspecific stranger (S1) and an empty chamber ( E ) in a 3-chamber social preference test. ( A ) PFC-PV-GFP (n = 8) and PFC-PV-TeLC (n = 10) animals spent significantly more time interacting with a conspecific mouse than with an empty chamber. ( B ) PFC-Lesion animals (n = 13) do not show a significant preference for social interaction. Example traces in ( A , B ) illustrate the travelled path. Increased density in the stranger compartment of PFC-PV-GFP, PFC-PV-TeLC and PFC-Saline (n = 9) but not Lesion animals indicates preference for social interaction. ( C,D ) Discrimination between a novel (S2) and a familiar (S1) conspecific. PFC-PV-GFP, PFC-PV-TeLC and PFC-Saline animals spent significantly more time with the novel mouse indicating social recognition. PFC-Lesion animals did not distinguish between novel and familiar animals. Dashed line indicates level where equal time is spent with familiar and stranger animals. ( E,F ) Response to amphetamine. ( E ) Path length in an open field of PFC-PV-GFP (n = 8) and PFC-PV-TeLC (n = 10) animals. Dashed line indicates amphetamine administration. Both groups show enhanced locomotor activity after amphetamine administration. Insets show cumulated path length during the amphetamine activity period. ( F ) PFC-Saline (n = 9) and PFC-Lesion (n = 13) animals before and after amphetamine administration. <anchor xml:id="a73"/>Both groups show enhanced locomotor activity after receiving amphetamine but PFC-Lesion animals show a hypersensitivity as indicated by increased peak locomotor activity (inset) and slower decay kinetics.<anchor xml:id="a74"/> Data are mean ± s.e.m. * P  &lt; 0.05; ** p  &lt; 0.01; ***p &lt; 0.001.</p>
        <p><anchor xml:id="a75"/>Accordingly social approach/avoidance behavior as well as social recognition memory/novelty preference depends on the PFC circuitry. PV-positive interneurons, however, do not seem to be a crucial component of this circuit.<anchor xml:id="a76"/></p>
        <p>Impaired signaling of PV-positive PFC interneurons does not alter behavioral sensitivity to psychostimulants</p>
        <p>Increased sensitivity to psychostimulants, such as amphetamine, is common in schizophrenia patients and considered a rodent correlate of the positive symptoms 45 , 50 , 51 . <anchor xml:id="a77"/>It is thought that both positive symptoms and increased amphetamine sensitivity are due to enhanced subcortical dopaminergic tone, which in turn correlates with and might be secondary to PFC dysfunction in schizophrenia<anchor xml:id="a78"/> 3 , 50 , 52 . <anchor xml:id="a79"/>Consistent with this idea, lesions of the PFC in rodents also increase amphetamine sensitivity and subcortical dopamine presumably through dysregulation of dopaminergic neurons in the ventral brainstem after loss of glutamatergic PFC afferent control<anchor xml:id="a80"/> 33 , 53 . Intraperitoneal injection of amphetamine caused a substantial increase in locomotor activity in all groups of mice with peak activity 10 to 15 minutes after injection ( Fig. 6E,F ). <anchor xml:id="a81"/>Compared with controls, PFC-Lesion animals showed significantly higher levels of locomotor activity ( Fig. 6F ), with increased peak activity ( p  = 0.04; t = 1.97) and slower decay kinetics ( p  = 0.005; t = 3.25), confirming the importance of the PFC for amphetamine sensitivity.<anchor xml:id="a82"/> <anchor xml:id="a83"/>In contrast, PFC-PV-TeLC animals did not differ from controls in amphetamine response (peak activity, t &lt; 1; activity decay, t &lt; 1)<anchor xml:id="a84"/> ( Fig. 6E ).</p>
        <p>These results support the idea that the PFC controls subcortical dopamine release and may thus be causally involved in the generation of positive symptoms 53 . <anchor xml:id="a85"/>However, PVIs do not seem to be required for this regulatory function of the PFC.<anchor xml:id="a86"/></p>
        <p>Discussion</p>
        <p>Schizophrenia presents with a complex blend of positive, negative and cognitive symptoms and PFC dysfunction may be causally involved in the origin of all three symptom categories. Within the PFC, alterations of the inhibitory circuitry, which appear to preferentially involve PVIs, are among the most robust histological findings. To detect PFC functions that depend on intact signaling of PVIs we contrasted PV-cell-specific with general perturbations of the PFC circuitry. <anchor xml:id="a87"/>We found that PFC lesions produced behavioral alterations in all three symptom categories, whereas selective inactivation of PVIs caused deficits only in the cognitive domain.<anchor xml:id="a88"/></p>
        <p><anchor xml:id="a89"/>Working memory represents a short-lasting on-line memory buffer that holds information relevant to ongoing tasks<anchor xml:id="a90"/> 54 . Although it is generally accepted that short-term memory relies on a distributed network of brain regions connected to and orchestrated by the PFC 35 , 55 , the physiological correlates of working memory are not clear. <anchor xml:id="a91"/>At the systems level synchronous network activity within the PFC and across functionally coupled brain structures may aid information processing during working memory 56 , 57 . <anchor xml:id="a92"/>Generation of network oscillations in turn is thought to depend on the activity of fast-spiking putative PVIs<anchor xml:id="a93"/> 58 , 59 , 60 , 61 . Here we show that PFC-dependent working memory indeed fully depends on intact transmission from PVIs.</p>
        <p><anchor xml:id="a94"/>Behavioral flexibility, which permits the individual to appropriate behavioral strategies to a changing environment, is another core function of the PFC that is impaired in schizophrenia<anchor xml:id="a95"/> 43 , 44 , 62 . The process may be mediated by PFC driven desynchronisation of network activity and thus functional uncoupling across task-relevant brain structures 63 . We have assessed behavioral flexibility in a water maze reversal task. Whereas both PFC-Lesion and PFC-PV-TeLC animals showed little difference in acquisition learning of a reference memory task, they needed more time to re-learn the platform position after its relocation. <anchor xml:id="a96"/>Analysis of reversal performance by subject revealed that this deficit was transient in PFC-PV-TeLC animals, where all mice eventually acquired the new location.<anchor xml:id="a97"/> By contrast, more than 30% of PFC-Lesion mice did not reach floor level after platform relocation suggesting that complete inactivation of the PFC circuitry induced more persistent impairments in reversal learning. Overall, our results indicate that impaired signaling of PFC PVIs leads to a transient failure to adjust behavioral responses to altered cue-reward associations.</p>
        <p>Among the negative symptoms in schizophrenia social withdrawal and impairments in social cognition represent core elements and are amenable to modeling in rodents 2 , 46 , 64 . We found that general PFC dysfunction impairs both social-approach avoidance behavior and social recognition memory. Similar results were obtained after PFC perturbations in rats and in DISC1 and neuregulin-1 mouse models of schizophrenia (for review see 47 , 64 ). Accordingly, optogenetic stimulation of the PFC has been shown to enhance social interaction in stressed mice 65 , presumably through prefrontal regulation of dopaminergic projections between ventral tegmental area (VTA) and nucleus accumbens and/or serotonergic raphe neurons 53 , 66 , 67 . Similarly, positive symptoms and enhanced amphetamine sensitivity in schizophrenia may result from deranged prefrontal control of brain stem dopamine neurons 3 , 33 , 50 , 52 , 53 . In line with this theory we found an enhanced peak and decelerated decay of the locomotor response to amphetamine in PFC-Lesion animals.</p>
        <p>The results we obtained after non-cell-type-selective inactivation in mice thus confirm that PFC dysfunction may be causally involved not only in cognitive symptoms but also in the emergence of positive and negative symptoms, presumably by affecting the complex mono- and polysynaptic prefrontal regulation of subcortical monaminergic pathways 53 , 66 . <anchor xml:id="a98"/>Interestingly, complete disruption of GABA A -receptor-mediated inhibition in the PFC by bicuculline infusion has been shown to cause similar behavioral alterations as those we report here for PFC-lesion animals<anchor xml:id="a99"/> 68 , 69 , 70 . <anchor xml:id="a100"/>In contrast, selective inactivation of one sub-population of GABAergic interneurons – PVIs – caused deficits only in the cognitive domain, suggesting that these interneurons may subserve specific circuit functions in the PFC.<anchor xml:id="a101"/> <anchor xml:id="a102"/>Such a “division of labor” scenario between different populations of interneurons is further supported by our finding that <anchor xml:id="a103"/>analogous tetanus toxin-based targeting of a different, somatostatin (Sst)-expressing, population of interneurons in the PFC of Sst-Cre mice 71 caused no change in working memory performance in the same task that was clearly impaired after inactivation of PVIs<anchor xml:id="a104"/> ( Fig. S3 ).</p>
        <p><anchor xml:id="a105"/>In summary, impaired signaling of PVIs in the PFC, which is thought to form a core pathology in schizophrenia, may be causally involved in the development of cognitive symptoms. However, amphetamine-hypersensitivity and deficits in social-approach avoidance behavior as indicators of positive and negative symptoms, respectively, are not precipitated by PVI dysfunction. Based on these data we suggest that different aspects of the composite symptomatology of PFC dysfunction in schizophrenia can be allocated to specific neuronal elements.<anchor xml:id="a106"/></p>
        <p>Materials and Methods</p>
        <p>All procedures involving experimental mice were in accordance with the United Kingdom Animals (Scientific Procedures) Act 1986 and were approved by the Ethical Review Committee of the University of Aberdeen.</p>
        <p>Production of recombinant adeno-associated viral vectors</p>
        <p>AAV vectors were produced as described previously 26 , 72 . Briefly, AAV virions were produced that contained a 1:1 ratio type 1 and type 2 capsid proteins by transfecting human embryonic kidney (HEK) 293 cells with the AAV backbone plasmids pAM-FLEX-TeLC or pAM-FLEX-GFP 26 and AAV1 (pH21), AAV2 (pRV1) helper plasmids along with the adenovirus helper plasmid pFdelta6 using the calcium phosphate method 72 . 48 hours post transfection the cells were harvested and AAVs purified using 1 ml HiTrap heparin columns (Sigma) and concentrated using Amicon Ultra centrifugal filter devices (Millipore). Infectious AAV particles (viral titre) were calculated by serially infecting HEK293 cells stably expressing Cre-recombinase 26 and counting GFP-positive cells.</p>
        <p>Animals, surgery and recording of local field potentials</p>
        <p>Homozygous PV-Cre 27 and Sst-Cre 71 mice were purchased from Jackson laboratories (Repository number: PV 008069; SST 013044) and maintained as homozygous colonies. All stereotaxic injections and behavioral testing were carried out on male and female homozygous PV-Cre or SST-Cre littermates starting between P42 and P56. Animals were housed in a temperature-controlled environment with a 12 hour light/dark cycle and free access to food and water. Stereotaxic surgery was carried out as in 26 . Briefly, anesthesia was induced with 3% isoflurane in O 2 by inhalation and maintained on 1.5–2% isoflurane throughout surgery. Heads of mice were fixed in a stereotaxic frame (Stoelting, USA), an incision was made on the skin above the skull and the skull exposed. Small holes were drilled relative to Bregma. The coordinates used were AP +2.0 mm, L ±1.0 mm, angle 17°, depth −2.6 mm. Lesions were made by injecting 1 μl of 1 mg/ml ibotenic acid, control animals received an injection of 1 μl vehicle (PBS). PFC-PV-GFP and PFC-PV-TeLC animals were injected with AAV-FLEX-GFP and AAV-FLEX-TeLC respectively. Both AAVs had a titer of about 6 × 10 6 infectious particles per μl. 2 μl of rAAV along with 1 μl of 20% mannitol solution (total 3 μl volume) were injected over a 20 minute period. Stereotaxic injections were made using a pulled glass pipette (VWR) with an 8 μm bore width. After removal of the glass pipette the burr hole was filled with bone wax, the skin replaced and fixed using Vetbond tissue adhesive (3M).</p>
        <p>For LFP recordings double twisted insulated gold wire depth electrodes (ADVENT Research Materials, Oxford, UK) were lowered bilaterally into prefrontal cortex (and an additional set into hippocampal CA1) at the same coordinates as viral deposition. Wires were externalized and a head-stage was formed of gold contact pins. Two gold plated watchmaker screws (TSE Systems GmbH, Germany) also connected to pins served as reference and ground respectively and were located above the posterior parietal cortex on either side of Lambda. Electrodes were anchored to the scull using dental cement and pins were covered with a low weight dummy connector.</p>
        <p>Post-operative analgesia was given as needed. Behavioural analysis began 10 days after stereotaxic injections. All animals were housed individually after surgery and during behavioural testing periods.</p>
        <p><anchor xml:id="a107"/>Local field potentials (LFPs) from PFC were recorded while animals were freely moving in their holding cage. Low weight dummies were removed and replaced by a wireless data logger for continuous recording of 4 channels and on board memory (NeuroLogger, New Behavior, Zurich, Switzerland), set at a sampling rate of 200 Hz.<anchor xml:id="a108"/> A total of 10 minutes were recorded, files were extracted from the Neurologgers using the customised CommSW application and further converted into .txt format using an in-house MatLAB script (MatLAB 8.3, The MathWorks Inc., Natick, USA). <anchor xml:id="a109"/>Artefact free continuous recordings (120s) of LFPs were chosen and spectral power analysis conducted using Fast Fourier Transform in BrainVision Analyzer 2.0 software<anchor xml:id="a110"/> (BrainProducts GmbH, Germany) using ASCII (American standard code for information interchange) data format with multiplexed orientation, time domain, and sampling interval of 5000 μs (200 Hz).</p>
        <p>Histology</p>
        <p>Mice were deeply anaesthetised by intraperitoneal injection of medetomidine/ketamine (1 and 6 mg per kg, respectively) and transcardially perfused with phosphate buffered saline (PBS) followed by 4% paraformaldehyde in PBS (PFA). After removal brains were post-fixed in PFA overnight at 4 °C. 50 μm coronal sections were taken on a VT1200S vibratome (Leica). Sections were permeabilised in 0.4% Triton X-100 for 30 minutes at room temperature and incubated with primary antibody overnight at 4°C in PBS containing 2% normal goat serum and 0.1% Triton X-100. Sections were washed three times in PBS containing 1% NGS for 10 minutes at room temperature and incubated with secondary antibody for 2.5 hours at room temperature. Sections were washed twice in PBS containing 1% NGS and once in PBS only for 10 minutes at room temperature, mounted on Superfrost glass slides (VWR International) and cover-slipped in Mowiol. Primary antibodies used were rabbit polyclonal GFP (1:1000) (Invitrogen), rabbit polyclonal PV (1:1000) (Swant), rabbit polyclonal VAMP2 (1:500) (Synaptic Systems), guinea pig polyclonal vesicular GABA transporter (vGAT; 1:500) (Synaptic Systems), mouse monoclonal GFP (1:1000) (Invitrogen). Secondary antibodies used were Alexa Fluor goat anti mouse 488, Alexa Fluor goat anti rabbit 488, Alexa Fluor goat anti mouse 647 (all Invitrogen; 1:1000) and goat anti rabbit Cy3 and goat anti guinea pig Cy5 (Jackson Immunoresearch; 1:500).</p>
        <p><anchor xml:id="a111"/>For analyses of GFP-TeLC-expessing PV-positive neurons (n = 9344 cells) sections were taken from at least 3 points along the rostro-caudal extent of the PFC and immunostained for GFP and PV.<anchor xml:id="a112"/> XY scans of the entire coronal section were taken on an epifluorescent Zeiss Axio Imager M1 microscope. Images of GFP and PV immunostaining were acquired separately and merged digitally in Adobe Photoshop (version CS3). The appropriate image of the mouse brain atlas 73 was digitally overlayed to delineate the brain section into regions. The total numbers of PV-positive and GFP-TeLC-positive neurons were counted in the following regions: prelimbic cortex, infralimbic cortex, cingulate cortex area 1, secondary motor cortex, ventral orbital cortex, medial orbital cortex. <anchor xml:id="a113"/>Water maze experiments were replicates of two cohorts. <anchor xml:id="a114"/>Only cohort 1 was quantitatively assessed (n = 10/17).<anchor xml:id="a115"/> For cohort 2 and all PFC-PV-GFP animals correct viral expression was confirmed visually.<anchor xml:id="a116"/></p>
        <p>For analysis of ibotenic acid lesions, brains were flash frozen in liquid nitrogen and 40 μm sections were cut on a cryostat (Leica) and mounted on superfrost plus slides. Sections were stained with cresyl violet and images captured with a Zeiss Axioimager M1 microscope. The mouse brain atlas was digitally overlayed and the lesion in each brain area calculated as a percentage of the total brain area in ImageJ.</p>
        <p>For analysis of VAMP2 expression three sections from four animals from both the PV-PFC-GFP and PV-PFC-TeLC groups were randomly selected and immunostained for VAMP2, vGAT and GFP. Images were taken using a Zeiss LSM 510 confocal microscope at equal exposure times for each image. <anchor xml:id="a117"/>Analysis was carried out blind to the experimental group.<anchor xml:id="a118"/> GFP or GFP-TeLC and vGAT-positive bouton-like structures were randomly chosen and traced using Zeiss Zen 2009 image software. Fluorescence intensity for VAMP2 within the traced area was measured as a mean grey scale value in ImageJ. In total 87 GFP-positive and 65 TeLC-positive puncta were analysed.</p>
        <p>Behavioural analysis</p>
        <p>Behavioral testing of Experiment 1 was performed in PFC-PV-TeLC mice (n = 10) first to detail the phenotypes relative to PFC-PV-GFP (n = 8) mice. In a second follow-on experiment PFC-Lesion mice (n = 13) were tested against PFC-Saline mice (n = 9). <anchor xml:id="a119"/>This experimental design precludes a direct 2 × 2 statistical comparison.<anchor xml:id="a120"/> The general sequence of testing was open field, hole board, Y-maze alternation, social interaction, water maze and amphetamine challenge. Water maze experiments of PFC-PV-TeLC and PFC-PV-GFP mice were replicates of two cohorts with n = 7 for each group in the second cohort.</p>
        <p>A separate cohort of PFC-Sst-GFP (n = 8) and PFC-Sst-TeLC (n = 11) was tested in a spontaneous alternation paradigm.</p>
        <p>Open field</p>
        <p>Motor activity was analysed in a square white Perspex arena (60 × 60 cm). Animals were placed in the arena and tracked for 10 minutes with an overhead CCTV camera, data was recorded onto a PC and analysed using Ethovision XT software (Noldus). The arena was cleaned thoroughly between animals to eliminate odour cues. We analysed path length travelled during the trial, time spent in periphery or centre (equi-area) and habituation, as measured by change in path length over time.</p>
        <p>Hole-board and reinvestigation</p>
        <p>The 40 cm by 40 cm hole board-arena was devoid of side walls and elevated 10 cm above the bench. It had 16 equi-distant holes containing infra-red sensors to record “nose-pokes” into the hole. The number of nose-pokes over a 5 minute period was recorded for each animal. Each trial was simultaneously recorded using an overhead CCTV camera for post-hoc analysis of reinvestigation. <anchor xml:id="a121"/>Reinvestigation was analyzed manually by an experimenter blind to the experimental group.<anchor xml:id="a122"/> The position of each nose-poke was noted, and the number of repeat pokes into previously explored holes was divided by the number of initial pokes. An animal that did not reinvestigate any holes would receive a score of 0.</p>
        <p>Match to place Y-maze</p>
        <p>The match to place Y-maze was carried out as detailed in 26 . Briefly, trials were carried out in a circular white Perspex pool 150 cm in diameter and 50 cm deep filled with water to a depth of 35 cm with water at 21 ± 1 °C. The arena was equipped with 8 radiating arms (arm length 55 cm, arm width 15 cm, central area 40 cm diameter). The protocol was a delayed matching to place test with 3 trials per day (max trial time 60s) and inter-trial intervals of 60 s. The mice were released into the start arm facing the wall. The first trial was a free swim/extinction trial with both the start arm and one possible goal arm open but without an accessible platform. In the second trial, a second goal arm containing the submerged platform was open (sample trial) and the animal released again from the start arm and allowed to find the hidden platform. If it did not find the platform within 60s it was guided to it by the experimenter. Trial 3 was a match trial, where the animal was again released from the start arm and was monitored for performance with the platform remaining in the same position. <anchor xml:id="a123"/>A perfect trial was defined as the animal leaving the start arm and immediately entering the goal arm.<anchor xml:id="a124"/> Entering the wrong arm or re-entering the start arm was counted as errors. Training was continued on consecutive days until control animals reached a criterion of &gt;70% correct match trials. Locations of arms and platform were varied pseudo-randomly each day to prevent spatial reference memory bias.</p>
        <p>Y-maze spontaneous alternation</p>
        <p>Spontaneous alternation was analysed in a white Perspex arena consisting of three equally sized arms in a “Y” configuration. The animal was placed at the end of one of the arms facing the wall and allowed to freely explore the arena for 10 minutes. Each trial was recorded using an overhead CCTV camera for post-hoc analysis. Trials were analysed manually by an experimenter blind to the experimental group and the sequence of arm entries noted. <anchor xml:id="a125"/>A complete alternation was defined as an animal entering each of the three arms in sequence without re-entering a previously explored arm.<anchor xml:id="a126"/> <anchor xml:id="a127"/>Percentage alternation was calculated as the number of total complete alternations, divided by the total number of arm entries minus two and expressed as a percentage.<anchor xml:id="a128"/></p>
        <p>Water maze and reversal learning</p>
        <p>Open field water maze and reversal learning was carried out in a white Perspex pool 150 cm in diameter and 50 cm deep filled with water to a depth of 35 cm with water at 21 ± 1 °C. The extra-maze environment contained numerous spatial cues. On days one to five animals were trained to locate a hidden platform with four trials per day and an inter-trial interval of 30 minutes. Animals were released from a position at one of the four cardinal compass points in a pseudorandom fashion with one release from each point per day. Maximum trial length was 90 seconds, if an animal failed to locate the platform within the trial period it was guided to it by the experimenter. Following training on day 5 the animals received a probe trial, where they were released opposite the “platform” location and allowed to swim for 60 seconds. On day 8 the animals received a “refresher” day where they were again trained to the original platform location. On day 9 the platform location was switched to the quadrant opposite to the original location and training continued for three further days. Following training on day 12 the animals again underwent a probe trial. Throughout all trials animals were tracked via an overhead CCTV camera connected to the PC running Any-Maze (Ugo Basile) software. Primary parameters analysed were path length, time in target quadrant, swim speed. As a secondary parameter we calculated the number of trials required to attain floor level performance (2 consecutive trials with ≤4 m path length in each trial). It provides a best performance scenario and contingency plots reveal the percentage of mice that met floor level for each trial.</p>
        <p>Social interaction</p>
        <p>Social interaction was examined essentially as described in 49 . The testing apparatus consisted of a three-compartment white Perspex box. Each compartment was 20 cm long, 42 cm wide and 22 cm high. Dividing walls were made from clear Perspex with small circular openings, 8 cm in diameter allowing free access to each chamber. The two outer compartments contained metal wire cages where conspecific animals were held, trials were recorded via an overhead CCTV camera connected to a PC and analyzed using Ethovision XT (Noldus). Test animals were first allowed a habituation period of 10 minutes where they could freely explore the apparatus without any stranger animals present. The test animal was removed from the apparatus for five minutes. Next the animals were tested for sociability, when a stranger junior conspecific (S1) was introduced to one of the side compartment cages (randomly selected and counterbalanced). The test animal was introduced to the central compartment and allowed to freely explore for 10 minutes. Time spent with the nose point of the test mouse in the immediate vicinity of the cage containing the stranger animal was taken as social interaction. The test animal was then removed from the apparatus for 5 minutes and a second stranger (S2) was introduced to the opposing cage, with the design counterbalanced so that stranger 1 could remain in the same position or move to the opposite location. The test animal was again introduced to the central compartment and allowed to freely explore for 10 minutes. <anchor xml:id="a129"/>Time spent with stranger 2 was divided by time spent with stranger 1 to give a discrimination index, where 1 (dashed line in Fig. 6C,D ) indicates equal time spent with each stranger.<anchor xml:id="a130"/> The apparatus was cleaned thoroughly between animals to eliminate odor cues.</p>
        <p>Amphetamine challenge</p>
        <p>Amphetamine challenge took place in the open field arena. Animals were placed in the centre of the arena and allowed to freely explore for 10 minutes. They were then given an intraperitoneal injection of 5 mg/kg D-amphetamine sulphate salt (Sigma-Aldrich) dissolved in saline. Animals were returned to the arena and monitored for a further 40 minutes, the arena was cleaned thoroughly between trials to minimise odor cues. Movements were recorded by an overhead CCTV camera and movements tracked using Ethovision XT software (Noldus).</p>
        <p>Statistical analysis</p>
        <p>Statistical analyses were performed using Minitab version 15 (Minitab, Inc.) or GraphPad Prism 5.0. <anchor xml:id="a131"/>Unless otherwise stated data were analysed with two-tailed paired or unpaired Student’s t-test as appropriate.<anchor xml:id="a132"/> <anchor xml:id="a133"/>We also used two-way ANOVA with treatment as between-subject and trial/day as within-subject factors.<anchor xml:id="a134"/> <anchor xml:id="a135"/>Contingency analysis applied Fisher’s exact or Chi-Square tests.<anchor xml:id="a136"/> <anchor xml:id="a137"/>The null hypothesis was rejected for alpha greater than 5%.<anchor xml:id="a138"/></p>
        <p>Additional Information</p>
        <p>How to cite this article : Murray, A. J. et al . Parvalbumin-positive interneurons of the prefrontal cortex support working memory and cognitive flexibility. Sci. Rep . 5 , 16778; doi: 10.1038/srep16778 (2015).</p>
        <p>Supplementary Material</p>
        <p>Supplementary Information</p>
        <p>srep16778-s1.docx (190.8KB, docx)</p>
        <p>Acknowledgments</p>
        <p>We were supported by the Biotechnology and Biological Sciences Research Council grant BB/H001123/1 (P.W.), the Medical Research Council grants G0601498 and G1100546/2 (P.W.), Tenovus Scotland Grant G09/17 (A.J.M.) and the University of Aberdeen (P.W.). We thank O. Tüscher for discussion, P. Teismann and the microscopy core facility at the University of Aberdeen for the use of microscopy equipment, L. Strachan, A. Plano, S. Deiana for help with behavioral testing.</p>
        <p>Footnotes</p>
        <p>Author Contributions A.J.M., G.R. and P.W. designed experiments. A.J.M., L.A.-B., M.W.-F., K.L.H.C., A.F. and B.C. performed experiments. Data were analyzed by A.J.M., M.W.-F., B.C., G.R. and P.W.; A.J.M., G.R. and P.W. wrote the manuscript.<anchor xml:id="a139"/></p>
    </body>
  </text>
</TEI>
